This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks Value Investor Highlights: Chemourr, Dillard's, Macy's, Micron and Western Digital
by Zacks Equity Research
Zacks Value Investor Highlights: Chemourr, Dillard's, Macy's, Micron and Western Digital
5 Tips for New Stock Investors
by Tracey Ryniec
Want to invest in stocks but unsure of how to get started?
Zacks.com highlights: Superior Uniform Group, H&E Equipment Services, Chemours, Applied Materials and Microchip Technology
by Zacks Equity Research
Zacks.com highlights: Superior Uniform Group, H&E Equipment Services, Chemours, Applied Materials and Microchip Technology
5 Solid Dividend Growth Stocks Below $100
by Sweta Killa
Dividend growth stocks under $100 that could lead to a healthy portfolio with a greater scope of capital appreciation.
Zacks.com featured highlights include: Pilgrim's Pride, Insight Enterprises, Dorman, Chemours and Crown
by Zacks Equity Research
Zacks.com featured highlights include: Pilgrim's Pride, Insight Enterprises, Dorman, Chemours and Crown
Why Chemours Company (CC) Could Beat Earnings Estimates Again
by Zacks Equity Research
Chemours Company (CC) has seen a nice short-term history of beating earnings estimates, and looks poised to crush analyst expectations in its next earnings report as well.
Grab Market Momentum With 5 Top Rising P/E Stocks
by Sanghamitra Saha
Forget undervalued stocks, play these top-ranked stocks with rising P/E.
5 Great Basic Materials Stocks to Buy Ahead of Q1 Earnings
by Swarup Gupta
Prospects of a sustained period of growth and a pickup in inflation are likely to brighten the prospects of basic materials companies
The Zacks Analyst Blog Highlights: Pioneer Natural, Chemours, Louisiana-Pacific and Timken
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Pioneer Natural, Chemours, Louisiana-Pacific and Timken
Bet on These Sector ETFs & Stocks for Q1 Earnings
by Sweta Killa
We have highlighted one ETF and one stock from the sectors that could make great plays as the Q1 earnings season unfolds.
Why Chemours Company (CC) Could Be an Impressive Growth Stock
by Zacks Equity Research
Chemours Company (CC) is seeing solid earnings estimate revision and has a favorable Zacks rank, making it well positioned for future earnings growth.
Is Chemours (CC) a Great Stock for Value Investors?
by Zacks Equity Research
Chemours (CC) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
Top Ranked Value Stocks to Buy for April 4th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, April 3rd:
Zacks.com highlights: Chemours, Activision Blizzard, Jones Lang LaSalle, Avery Dennison and Applied Materials
by Zacks Equity Research
Zacks.com highlights: Chemours, Activision Blizzard, Jones Lang LaSalle, Avery Dennison and Applied Materials
Monsanto (MON) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Higher sales and cost-control measures to boost Monsanto's (MON) earnings in second-quarter fiscal 2018. However, headwinds like input price volatility and industry rivalry remain a drag.
5 Top Dividend Growth Stocks to Buy Amid Market Turmoil
by Sweta Killa
A history of year-over-year dividend growth leads to a healthy portfolio with greater scope of capital appreciation.
Chemours (CC) Looks Good: Stock Adds 5.4% in Session
by Zacks Equity Research
Chemours (CC) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
5 Dirt Cheap 'Strong Buy' Stocks
by Tracey Ryniec
Single digit P/Es and rising earnings estimates make for a powerful combination.
5 Discounted PEG Stocks for Value Investors
by Zacks Equity Research
PEG-based investing can turn out to be more rewarding if some other relevant parameters are taken into consideration.
Zacks.com highlights: Marriott International, American Equity Investment Life Holding, Chemours, FleetCor Technologies and CBRE Group
by Zacks Equity Research
Zacks.com highlights: Marriott International, American Equity Investment Life Holding, Chemours, FleetCor Technologies and CBRE Group
5 Stocks with Steady Sales Growth to Invest in Right Now
by Zacks Equity Research
Sales growth is an important indicator of a company's health and ability to sustain its business.
Is a Surprise Coming for Chemours (CC) This Earnings Season?
by Zacks Equity Research
Chemours (CC) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.
Zacks.com featured highlights: Tata Motors, POSCO, Newtek Business Services and Chemours
by Zacks Equity Research
Zacks.com featured highlights: Tata Motors, POSCO, Newtek Business Services and Chemours
4 High Earnings Yield Stocks to Boost Your Portfolio
by Zacks Equity Research
Earnings yield is a helpful metric in comparing a stock with other stocks and with fixed income securities. A stock with higher earnings yield generates better returns.
3 Stocks To Buy On The Dip Right Now
by Ryan McQueeney
The "Buy the dips" strategy is exactly what it sounds like: following a significant drop in the price of a stock, bullish investors will scoop up shares at what they believe is a discount. Check out these three stocks to buy on the dip right now!